BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 28882609)

  • 1. Atypical meningioma. A study on recurrence and disease-specific survival.
    Champeaux C; Houston D; Dunn L
    Neurochirurgie; 2017 Sep; 63(4):273-281. PubMed ID: 28882609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment.
    Champeaux C; Wilson E; Shieff C; Khan AA; Thorne L
    J Neurooncol; 2016 Sep; 129(2):337-45. PubMed ID: 27311726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment.
    Champeaux C; Dunn L
    World Neurosurg; 2016 May; 89():180-6. PubMed ID: 26850975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment.
    Champeaux C; Jecko V
    Neurochirurgie; 2016 Aug; 62(4):203-8. PubMed ID: 27339832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
    Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
    Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Health Organization grade II meningiomas.
    Champeaux C; Dunn L
    Acta Neurochir (Wien); 2016 May; 158(5):921-9; discussion 929. PubMed ID: 27020441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery for convexity meningioma: Simpson Grade I resection as the goal: clinical article.
    Hasseleid BF; Meling TR; Rønning P; Scheie D; Helseth E
    J Neurosurg; 2012 Dec; 117(6):999-1006. PubMed ID: 23061394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
    Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
    J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series.
    Pessina F; Navarria P; Clerici E; Soffietti R; Nibali MC; Rudà R; Riva M; Scorsetti M; Bello L
    World Neurosurg; 2019 Mar; 123():e273-e279. PubMed ID: 30496926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant?
    Gallagher MJ; Jenkinson MD; Brodbelt AR; Mills SJ; Chavredakis E
    Clin Neurol Neurosurg; 2016 Feb; 141():117-21. PubMed ID: 26780494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant Meningioma: An International Multicentre Retrospective Study.
    Champeaux C; Jecko V; Houston D; Thorne L; Dunn L; Fersht N; Khan AA; Resche-Rigon M
    Neurosurgery; 2019 Sep; 85(3):E461-E469. PubMed ID: 30566646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
    Palma L; Celli P; Franco C; Cervoni L; Cantore G
    J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear cell histology portends a worse prognosis than other WHO grade II histologies.
    Soni P; Shao J; Momin A; Lopez D; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
    J Neurooncol; 2021 Jan; 151(2):307-312. PubMed ID: 33398533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence.
    Zhang H; Ma L; Wang YB; Shu C; Kuang W; Huang YA; Dong LQ; Cheng GG
    World Neurosurg; 2017 Jan; 97():693-700.e11. PubMed ID: 27744084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.
    Gousias K; Schramm J; Simon M
    J Neurosurg; 2016 Sep; 125(3):551-60. PubMed ID: 26824369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
    Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
    World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simpson grade: an opportunity to reassess the need for complete resection of meningiomas.
    Heald JB; Carroll TA; Mair RJ
    Acta Neurochir (Wien); 2014 Feb; 156(2):383-8. PubMed ID: 24193889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors.
    Bender L; Somme F; Lhermitte B; Ahle G; Boone M; Blonski M; Pouget C; Truc G; Cebula H; Noël G
    Chin Clin Oncol; 2021 Jun; 10(3):26. PubMed ID: 33752411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases.
    Zhang GJ; Zhang GB; Zhang YS; Li H; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
    World Neurosurg; 2018 Apr; 112():e754-e762. PubMed ID: 29382616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningeal haemangiopericytoma and solitary fibrous tumour: a retrospective bi centre study for outcome and prognostic factor assessment.
    Champeaux C; Khan AA; Wilson E; Thorne L; Dunn L
    J Neurooncol; 2017 Sep; 134(2):387-395. PubMed ID: 28691143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.